NCT02269176View on ClinicalTrials.gov

Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

January 31, 2001

Conditions
Hypertension
Interventions
DRUG

Low dose of telmisartan

DRUG

High dose of telmisartan

DRUG

Low dose of losartan

DRUG

High dose of losartan

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY